133 related articles for article (PubMed ID: 12449148)
1. [Effects of pamidronate disodium (Bonin) combined with chemotherapy on bone pain in multiple myeloma].
Leng Y; Chen SL; Shi HZ
Space Med Med Eng (Beijing); 2002 Oct; 15(5):377-8. PubMed ID: 12449148
[TBL] [Abstract][Full Text] [Related]
2. [Disodium pamidronate (APD) in the treatment of bone metastases].
Costa L; Moreira C; da Costa EB
Acta Med Port; 1993 Feb; 6(2):71-3. PubMed ID: 8488764
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience).
Kraj M; Pogłód R; Maj S; Pawlikowski J; Sokołowska U; Szczepanik J
Acta Pol Pharm; 2002; 59(6):478-82. PubMed ID: 12669777
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.
Berenson JR; Lichtenstein A; Porter L; Dimopoulos MA; Bordoni R; George S; Lipton A; Keller A; Ballester O; Kovacs MJ; Blacklock HA; Bell R; Simeone J; Reitsma DJ; Heffernan M; Seaman J; Knight RD
N Engl J Med; 1996 Feb; 334(8):488-93. PubMed ID: 8559201
[TBL] [Abstract][Full Text] [Related]
5. The role of disodium pamidronate in the management of bone pain due to malignancy.
Groff L; Zecca E; De Conno F; Brunelli C; Boffi R; Panzeri C; Cazzaniga M; Ripamonti C
Palliat Med; 2001 Jul; 15(4):297-307. PubMed ID: 12054147
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates in multiple myeloma.
Berenson JR
Cancer; 1997 Oct; 80(8 Suppl):1661-7. PubMed ID: 9362433
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic options in the management of myeloma bone disease.
Berenson JR
Semin Oncol; 2010 Jun; 37 Suppl 1():S20-9. PubMed ID: 20682368
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate therapy in multiple myeloma.
Laakso M; Jantunen E
Acta Oncol; 1996; 35 Suppl 5():55-6. PubMed ID: 9142966
[TBL] [Abstract][Full Text] [Related]
9. Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review.
Alegre A; Gironella M; Bailén A; Giraldo P
Eur J Haematol; 2014 Mar; 92(3):181-8. PubMed ID: 24330023
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate therapy in the treatment of multiple myeloma.
Lawson MA; Ashcroft J; Croucher PI
Curr Pharm Des; 2010; 16(27):3028-36. PubMed ID: 20722619
[TBL] [Abstract][Full Text] [Related]
11. Effect of pamidronate on skeletal morbidity in myelomatosis. Part 1. The results of the first 12 months of pamidronate therapy.
Kraj M; Pogłód R; Pawlikowski J; Maj S; Nasiłowska B
Acta Pol Pharm; 2000 Nov; 57 Suppl():113-6. PubMed ID: 11293237
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial.
Rosen LS; Gordon D; Kaminski M; Howell A; Belch A; Mackey J; Apffelstaedt J; Hussein MA; Coleman RE; Reitsma DJ; Chen BL; Seaman JJ
Cancer; 2003 Oct; 98(8):1735-44. PubMed ID: 14534891
[TBL] [Abstract][Full Text] [Related]
13. Management of bone disease in multiple myeloma.
Terpos E; Berenson J; Raje N; Roodman GD
Expert Rev Hematol; 2014 Feb; 7(1):113-25. PubMed ID: 24433088
[TBL] [Abstract][Full Text] [Related]
14. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.
Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E
Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480
[TBL] [Abstract][Full Text] [Related]
15. Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer.
Small EJ; Smith MR; Seaman JJ; Petrone S; Kowalski MO
J Clin Oncol; 2003 Dec; 21(23):4277-84. PubMed ID: 14581438
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy did not enhance the anti-osteolytic effects of bisphosphonate in multiple myeloma bone disease.
Ogata A; Kitano M; Hashimoto N; Iwasaki T; Hamano T; Kakishita E
J Bone Miner Metab; 2002; 20(4):240-2. PubMed ID: 12115071
[No Abstract] [Full Text] [Related]
17. Treatment of painful bone lesions and hypercalcemia.
Ascari E; Attardo-Parrinello G; Merlini G
Eur J Haematol Suppl; 1989; 51():135-9. PubMed ID: 2534078
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of samarium-153-ethylenediaminetetramethylene phosphonic acid with pamidronate disodium in the treatment of patients with painful metastatic bone cancer.
Wang RF; Zhang CL; Zhu SL; Zhu M
Med Princ Pract; 2003; 12(2):97-101. PubMed ID: 12634464
[TBL] [Abstract][Full Text] [Related]
19. Combination of pamidronate and thalidomide in the therapy of treatment-resistant multiple myeloma.
Ciepłuch H; Baran W; Hellmann A
Med Sci Monit; 2002 Apr; 8(4):PI31-6. PubMed ID: 11951079
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumour activity of bisphosphonates in human myeloma cells.
Shipman CM; Rogers MJ; Apperley JF; Graham R; Russell G; Croucher PI
Leuk Lymphoma; 1998 Dec; 32(1-2):129-38. PubMed ID: 10037008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]